Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Descriptor ID |
D003924
|
| MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
| Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Noninsulin-Dependent
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- NIDDM
- Diabetes Mellitus, Noninsulin Dependent
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Noninsulin-Dependent Diabetes Mellitus
- Noninsulin Dependent Diabetes Mellitus
- Maturity-Onset Diabetes
- Diabetes, Maturity-Onset
- Maturity Onset Diabetes
- Type 2 Diabetes
- Diabetes, Type 2
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 3 | 7 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 5 | 2 | 7 |
| 2000 | 3 | 0 | 3 |
| 2001 | 2 | 2 | 4 |
| 2002 | 11 | 1 | 12 |
| 2003 | 12 | 6 | 18 |
| 2004 | 22 | 4 | 26 |
| 2005 | 11 | 9 | 20 |
| 2006 | 16 | 3 | 19 |
| 2007 | 12 | 5 | 17 |
| 2008 | 12 | 4 | 16 |
| 2009 | 19 | 3 | 22 |
| 2010 | 27 | 5 | 32 |
| 2011 | 28 | 7 | 35 |
| 2012 | 45 | 8 | 53 |
| 2013 | 36 | 9 | 45 |
| 2014 | 36 | 10 | 46 |
| 2015 | 45 | 7 | 52 |
| 2016 | 33 | 11 | 44 |
| 2017 | 38 | 16 | 54 |
| 2018 | 31 | 7 | 38 |
| 2019 | 38 | 9 | 47 |
| 2020 | 62 | 8 | 70 |
| 2021 | 61 | 11 | 72 |
| 2022 | 73 | 2 | 75 |
| 2023 | 57 | 3 | 60 |
| 2024 | 60 | 12 | 72 |
| 2025 | 38 | 8 | 46 |
| 2026 | 20 | 4 | 24 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Impaired arginine, citrulline, and glutamine metabolism in type 2 diabetes: insights from a stable isotope study. J Clin Endocrinol Metab. 2026 Jun 17; 111(7):1967-1979.
-
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial. Lancet. 2026 Jun 20; 407(10547):2503-2514.
-
AANA Journal Course-GLP-1 Receptor Agonists: What CRNAs Need to Know About Their Expanding Role. AANA J. 2026 Jun 01; 94(3):225-233.
-
Effect of the initial combination approach vs initial monotherapy approach on 1-year trajectories of adherence in drug-naive patients with type 2 diabetes. J Manag Care Spec Pharm. 2026 Jun; 32(6):717-734.
-
Triple oral therapy combining metformin, SGLT-2 and DPP-4 inhibitors versus dual therapy in type 2 diabetes mellitus: A systematic review and meta-analysis. Medicine (Baltimore). 2026 May 29; 105(22):e49050.
-
Type 2 Diabetes and the Lung - Cause and Consequence. Curr Diab Rep. 2026 May 07; 26(1).
-
Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program. Atherosclerosis. 2026 Jun; 417:120758.
-
A Digital Diabetes Prevention Program for Hispanic Adolescents (Fit24+): Protocol for a Feasibility Randomized Controlled Trial. JMIR Res Protoc. 2026 Apr 15; 15:e75331.
-
Evaluation of Postpartum Glucose Tolerance Test Results Based on Criteria and Timing. Obstet Gynecol. 2026 Jul 01; 148(1):4-10.
-
Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study. Ophthalmology. 2026 Jul; 133(7):837-851.